Hospira, now a wholly owned subsidiary of Pfizer
Quick facts
Phase 3 pipeline
- DA-9501 · Hepatology / Gastroenterology
DA-9501 is a standardized herbal extract that modulates inflammatory and immune pathways to improve hepatic function and reduce liver injury.
Phase 2 pipeline
- Dexmedetomidine, midazolam; fentanyl · Oncology
Alpha-2 adrenergic receptor agonist - Epoetin biosimilar · Oncology
Stimulates erythropoiesis by binding to the erythropoietin receptor
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Hospira, now a wholly owned subsidiary of Pfizer portfolio CI brief
- Hospira, now a wholly owned subsidiary of Pfizer pipeline updates RSS
Frequently asked questions about Hospira, now a wholly owned subsidiary of Pfizer
What is Hospira, now a wholly owned subsidiary of Pfizer's pipeline?
Hospira, now a wholly owned subsidiary of Pfizer has 1 drugs in Phase 3, 2 in Phase 2, 5 in Phase 1. Late-stage candidates include DA-9501.
Related
- Sector hub: All tracked pharma companies